BioLife Corp (BLFS): Rega marang dodolan
BioLife Solutions, Inc. (BLFS) maintains a stable cash flow driven by the integration of its media into FDA regulations. The current P/S multiple illustrates this resilience, with 18.40 defining the current value of the metric. Revenue is based on the sale of laboratory systems and cryopreservation media. The brand's impeccable authority in the gene therapy sector guarantees maximum B2B partner loyalty and supply reliability.
Rincian analitis perusahaan BioLife Corp (BLFS)
- rega lan prakiraan konsensus rega:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Utang Agregat marang Modal BioLife Solutions, Inc.|BLFS - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal BioLife|BLFS - Utang perusahaan|Utang-utang marang nilai buku BioLife Corp|BLFS - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan BioLife Solutions|Koefisien jangkoan perantara biolifesolutions.com
- rincian asil keuangan lan kelipatan valuasi:
BLFS - Penghasilan resik|Penghasilan resik sing dikarepake BioLife Solutions, Inc.|BLFS - Pangali P/E|Kapitalisasi marang proyeksi bathi BioLife Solutions Inc|BLFS - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan BioLife Corp|BLFS - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan BioLife Solutions|BLFS - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan biolifesolutions.com|BLFS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioLife Solutions, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis fundamental perusahaan:BLFS - biolifesolutions.com
The P/S ratio correlates the market value of the business with its annual revenue, allowing for an assessment of real demand for shares regardless of current profitability. Analyzing the price-to-sales ratio helps filter out speculative noise, confirming the value of BioLife Solutions, Inc. (BLFS) through stable revenue from cell storage consumables, which create long-term customer dependency on the company's infrastructure.
Pesaing BioLife Solutions, Inc.
Koefisien rega marang pendapatan Tempus AI|Rasio rega marang pendapatan Qiagen QGEN|Ionis Pharmaceuticals, Inc. (IONS) - Rega marang dodolan|RGEN - Rasio rega marang pendapatan|RNA: Rasio rega marang pendapatan|CRSP (CRISPR Therapeutics AG) - Kapitalisasi marang pendapatan|genedx.com (WGS) - Multiplikator P/S|Kapitalisasi marang pendapatan RARE|BEAM (Beam Therapeutics Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S SRPT|Koefisien rega marang pendapatan Twist Bioscience Corp|Rasio rega marang pendapatan 10x Genomics, Inc. TXG|intelliatx.com (NTLA) - Rega marang dodolan|STOK - Rasio rega marang pendapatan|WVE (Wave Life Sciences Ltd) - Rasio kapitalisasi marang pendapatan|Maze Tx (MAZE) - Rasio rega marang pendapatan|SION - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PRME|TSHA: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QURE|Koefisien rega marang pendapatan MeiraGTx Holdings|Rasio rega marang pendapatan Regenxbio RGNX|SLDB: Rasio kapitalisasi marang pendapatan|Ocugen, Inc. - Multiplikator P/S|pacb.com (PACB) - Kapitalisasi marang pendapatan|BNTC (Benitec Biopharma) - Kapitalisasi marang pendapatan|DSGN - Koefisien rega marang pendapatan|RCKT (Rocket Pharmaceuticals Inc) - Multiplikator P/S|Rasio rega marang pendapatan FDMT|Rasio rega marang pendapatan Lexeo Therapeutics (LXEO)|Rasio rega marang pendapatan KRRO (korrobio.com)|Multiplikator P/S EDIT (Editas Medicine)|SLN (Silence Therapeutics PLC) - Rasio rega marang dodolan|PRQR - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Codexis, Inc. CDXS|SGMO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan NAUT|Rasio rega marang pendapatan Metagenomi|Rasio kapitalisasi marang pendapatan DTIL (precisionbiosciences.com)|Multiplikator P/S GBIO|Multiplikator P/S Boundless Bio Inc (BOLD)|Multiplikator P/S XCUR (Exicure)|Imunon Inc - Rasio rega marang pendapatan|RXi Pharmaceuticals - Multiplikator P/S|Koefisien rega marang pendapatan Mustang Bio, Inc. MBIO|transcodetherapeutics.com (RNAZ) - Rasio rega marang pendapatan|Rega marang dodolan Bionano Genomics (BNGO)|Rasio rega marang pendapatan Applied DNA Sciences|Rasio rega marang pendapatan BLUE|Multiplikator P/S IPA|Koefisien rega marang pendapatan Omega Therapeutics Inc|Multiplikator P/S OMIC (Singular Genomics Systems Inc)|RGLS (Regulus) - Rasio rega marang dodolan|Syros Pharmaceuticals - Multiplikator P/S|Rega marang dodolan telesisbio.com|TCON (TRACON Pharmaceuticals, Inc.) - Kapitalisasi marang pendapatan|Unity Biotechnology Inc. - Rasio kapitalisasi pasar marang pendapatan
